Physician profile
Pete Mayfield
NPI 1396700647
$872.06
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $791 · 2020: $52.55 · 2021: $12.98 · 2022: $15.48.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $176.66 | 2019-2020 | |
| Pfizer INC. | $162.70 | 2019-2020 | |
| Amgen INC. | $133.87 | 2019 | |
| Amarin Pharma, INC. | $105.00 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.22 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $47.31 | 2019 | |
| Novo Nordisk INC | $39.41 | 2019 | |
| Genentech USA, INC. | $20.59 | 2019 | |
| Daiichi Sankyo INC. | $20.19 | 2019 | |
| Allergan, INC. | $16.02 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $15.48 | 2022 | |
| Abbvie INC. | $12.98 | 2021 | |
| Sanofi-Aventis U.S. LLC | $12.12 | 2019 | |
| Lilly USA, LLC | $11.48 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $11.23 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $11.05 | 2019 | |
| Merck Sharp & Dohme LLC | $10.82 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $9.93 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pete Mayfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.